A carregar...

SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer

Immunotherapeutic strategies including the blockade of programmed death 1 (PD-1) receptors hold promise for the treatment of various cancers including non-small cell lung carcinoma (NSCLC). Preclinical data suggest that pre-existing tumor immunity is important for disease regression upon checkpoint...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dhodapkar, Kavita M, Gettinger, Scott N, Das, Rituparna, Zebroski, Henry, Dhodapkar, Madhav V
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3782159/
https://ncbi.nlm.nih.gov/pubmed/24073380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.25205
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!